MedTrace Logo

geRman-widE mulTicenter Analysis of oRal Anticoagulation-associated intraCerebral hEmorrhage

NCT01829581 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1205

Last updated 2014-02-26

No results posted yet for this study

Summary

Intracerebral hemorrhage \[ICH\] is the most feared complication of anticoagulant therapy \[OAC\]. Evidence regarding acute therapeutic interventions as well as secondary treatment approaches is still limited. Therefore, this German-wide observational cohort study will retrospectively identify and evaluate all OAC-associated ICH patients that have been admitted to the 20 participating tertiary centres over a 5-year period. The main focus of this investigation, besides epidemiological aspects, will be the (i) acute management of OAC-ICH, (ii) secondary therapy (anticoagulant management) and (iii) long-term outcome after OAC-ICH.

Conditions

  • OAC-ICH
  • Acute Management of OAC-ICH
  • Resumption of OAC

Interventions

OTHER

no intervention, only descriptive data analysis

Sponsors & Collaborators

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Hagen B. Huttner, MD · Department of Neurology, University of Erlangen-Nuremberg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-06-30
Completion
2014-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01829581 on ClinicalTrials.gov